In 2023, Germany led European labor costs in the pharmaceutical sector with €38.13 million, followed by Italy at €16.11 million and France at €14.92 million. Belgium and Spain contributed €10.95 million and €7.8 million respectively. Austria reported €4.5 million, with the Netherlands at €3.35 million. Smaller contributors included Slovenia, Greece, and Finland with values ranging between €1.76 million and €1.03 million. Lithuania and Estonia represented the minimal shares.
Year-on-year, Germany's costs rose by 3.75%, Belgium by 3.14%, and Austria by 2.87%. The Netherlands observed a rise of only 0.34%. Over the past five years, projected growth remains steady, reflecting moderate sector expansion.
Future trends to monitor include digital transformation in production, shifts in regulatory landscapes, and a potential increase in labor costs driven by skills shortages and inflationary pressures. Sustainable practices and technological advancements could further influence labor dynamics across Europe.
Top countries in Labour Costs in Basic Pharmaceutical Products and Pharmaceutical Preparations Share by Country (Million Euros)
| # | 10 Countries | Percent | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 38.13 | 2023 | +2.27% | +3.75% | View data |
| 2 | 2 Italy | 16.11 | 2023 | +1.18% | +1.61% | View data |
| 3 | 3 France | 14.92 | 2023 | +0.81% | +0.87% | View data |
| 4 | 4 Belgium | 10.95 | 2023 | +2.72% | +3.14% | View data |
| 5 | 5 Spain | 7.8 | 2023 | +0.9% | +1.08% | View data |
| 6 | 6 Austria | 4.5 | 2023 | +2.78% | +2.87% | View data |
| 7 | 7 Netherlands | 3.35 | 2023 | +0.5% | +0.34% | View data |
| 8 | 8 Slovenia | 1.76 | 2023 | +2.78% | +2.56% | View data |
| 9 | 9 Greece | 1.34 | 2023 | +1.01% | +1.75% | View data |
| 10 | 10 Finland | 1.03 | 2023 | +1.64% | +2.14% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
